Published on
December 12, 2024
- 09:00 GMT
VERAXA and Navigo Initiate Collaboration to Establish Pre-Targeting Strategies for Novel Affilin® Radio Conjugates
The agreement brings together Navigo Protein’s Affilin® platform with VERAXA’s proprietary click chemistry platform and conjugation expertise. HEIDELBERG, GERMANY, December 12, 2024 /EINPresswire.com/ -- HEIDELBERG, and HALLE, Germany, December 12, 2024 …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
